(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 28611.10 | 27319.90 | 4.73 | 84225.60 | 89162.80 | -5.54 | 117716.70 | 110559.30 | 6.47 |
| Other Income | 171.00 | 354.70 | -51.79 | 1177.80 | 1618.30 | -27.22 | 2169.90 | 1290.90 | 68.09 |
| PBIDT | 2322.30 | 2437.00 | -4.71 | 8564.40 | -910.20 | -1040.94 | 4261.30 | 21731.50 | -80.39 |
| Interest | 307.50 | 158.10 | 94.50 | 690.00 | 488.90 | 41.13 | 734.70 | 406.20 | 80.87 |
| PBDT | 2014.80 | 2278.90 | -11.59 | 7874.40 | -1399.10 | -662.82 | 3526.60 | 21325.30 | -83.46 |
| Depreciation | 1340.30 | 1279.10 | 4.78 | 4021.40 | 3831.70 | 4.95 | 5141.90 | 5028.30 | 2.26 |
| PBT | 674.50 | 999.80 | -32.54 | 3853.00 | -5230.80 | -173.66 | -1615.30 | 16297.00 | -109.91 |
| TAX | 270.50 | -4304.60 | -106.28 | 791.00 | -3702.70 | -121.36 | 271.70 | 3710.80 | -92.68 |
| Deferred Tax | 142.90 | -5455.40 | -102.62 | 86.30 | -3725.70 | -102.32 | -306.30 | 82.30 | -472.17 |
| PAT | 404.00 | 5304.40 | -92.38 | 3062.00 | -1528.10 | -300.38 | -1887.00 | 12586.20 | -114.99 |
| Equity | 909.60 | 908.40 | 0.13 | 909.60 | 908.40 | 0.13 | 909.00 | 907.40 | 0.18 |
| PBIDTM(%) | 8.12 | 8.92 | -9.01 | 10.17 | -1.02 | -1096.12 | 3.62 | 19.66 | -81.58 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: